⌘K
Loading ticker…
Replimune Group, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Replimune Group, Inc. (REPL) has a 3-month relative strength percentile of 90 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 70. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 10.7%, relative volume 1.59×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 90, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
REPL is held by 5 ETFs as of Mar 2026. Top owner: XBI at 0.23% weight, $17M notional. Top 3 carry $44M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| XBIState Street SPDR S&P Biotech ETF | 0.23% | $17M |
| VTIVanguard Total Stock Market ETF | 0.00% | $14M |
| IWMiShares Russell 2000 ETF | 0.02% | $13M |
| VXFVanguard Extended Market ETF | 0.01% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $837K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | REPL Jan avg: -4.45% median: -2.78% win: 50% σ: 18.20% n: 4 2022-04-12 → 2026-05-29 | REPL Feb avg: -2.82% median: -0.24% win: 50% σ: 15.28% n: 4 2022-04-12 → 2026-05-29 | REPL Mar avg: -11.81% median: -12.07% win: 25% σ: 11.16% n: 4 2022-04-12 → 2026-05-29 | REPL Apr avg: -19.92% median: -5.95% win: 20% σ: 27.32% n: 5 2022-04-12 → 2026-05-29 | REPL May avg: 42.62% median: -8.18% win: 40% σ: 109.93% n: 5 2022-04-12 → 2026-05-29 | REPL Jun avg: 29.20% median: 21.29% win: 100% σ: 28.98% n: 4 2022-04-12 → 2026-05-29 (current) | REPL Jul avg: -3.04% median: 0.52% win: 50% σ: 17.03% n: 4 2022-04-12 → 2026-05-29 | REPL Aug avg: -6.43% median: -2.11% win: 25% σ: 11.34% n: 4 2022-04-12 → 2026-05-29 | REPL Sep avg: -10.06% median: -12.80% win: 25% σ: 13.02% n: 4 2022-04-12 → 2026-05-29 | REPL Oct avg: 32.75% median: 6.80% win: 75% σ: 67.10% n: 4 2022-04-12 → 2026-05-29 | REPL Nov avg: 2.68% median: 7.13% win: 75% σ: 18.63% n: 4 2022-04-12 → 2026-05-29 | REPL Dec avg: -2.13% median: -8.40% win: 25% σ: 24.98% n: 4 2022-04-12 → 2026-05-29 |